Dietary intake of vitamin D and calcium and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition by Abbas, Sascha et al.
 Abbas 1 
Dietary intake of vitamin D and calcium and breast cancer risk in the European 
Prospective Investigation into Cancer and Nutrition 
 
Sascha Abbas1,2, Jakob Linseisen1,3 , Sabine Rohrmann1,4, Jenny Chang-Claude1, Petra H 
Peeters5, Pierre Engel6, Magritt Brustad7, Eiliv Lund7, Guri Skeie7 , Anja Olsen8, Anne 
Tjønneland8, Kim Overvad9, Marie-Christine Boutron-Ruault6, Francoise Clavel-Chapelon6, 
Guy Fagherazzi6, Rudolf Kaaks1, Heiner Boeing10, Brian Buijsse10, George Adarakis11, 
Vassilis Ouranos11, Antonia Trichopoulou11,12, Giovanna Masala13, Vittorio Krogh14, Amalia 
Mattiello15, Rosario Tumino16, Carlotta Sacerdote17,18, Genevieve Buckland19, Marcial 
Vicente Argüelles Suárez20, Maria-José Sánchez21,22, Maria-Dolores Chirlaque 22,23, Aurelio 
Barricarte22,24, Pilar Amiano22,25, Jonas Manjer26, Elisabet Wirfält27, Per Lenner28, Malin 
Sund29, H.B(as). Bueno-de-Mesquita30,31, Fränzel J.B. van Duijnhoven30,32, Kay-Tee Khaw33, 
Nick Wareham34, Timothy J Key35, Veronika Fedirko36, Isabelle Romieu36, Valentina Gallo37, 
Teresa Norat37, Petra A Wark37, Elio Riboli37 
 
1 German Cancer Research Center, Division of Cancer Epidemiology, Heidelberg, Germany 
 
2 PMV Research Group at the Department of Child and Adolescent Psychiatry and 
Psychotherapy, University of Cologne, Cologne, Germany  
 
3 Helmholtz Zentrum München, Institute of Epidemiology, Neuherberg, Germany  
 
4 Institute of Social and Preventive Medicine, University of Zurich, Switzerland 
 
5 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 
Utrecht, The Netherlands 
 
6 Inserm Team 9 U1018 Center for Research in Epidemiology and Population Health, Team 9 
and Paris South University, Institut Gustave-Roussy, Villejuif, France 
 
7 Department of Community Medicine, University of Tromsø, Tromsø, Norway 
 
8 Danish Cancer Society Research Center, Copenhagen, Denmark 
 
9 Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, 
Denmark 
 
 1 
 Abbas 2 
10 Department of Epidemiology, German Institute of Human Nutrition (DIfE) Potsdam-
Rehbrücke, Nuthetal, Germany 
 
11 Hellenic Health Foundation, Athens, Greece 
 
12 WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, 
Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece  
 
13 Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute – 
ISPO, Florence, Italy 
 
14 Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy 
 
15 Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy 
 
16 Cancer Registry and Histopathology Unit, ‘Civile-M.P. Arezzo’ Hospital, Ragusa, Italy 
 
17 Human Genetics Foundation, Turin, Italy 
 
18 CPO-Piemonte, Turin, Italy 
 
19 Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, 
Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain 
 
20 Public Health Directorate, Asturias, Spain 
 
21 Andalusian School of Public Health, Granada, Spain 
 
22 CIBER Epidemiologia y Salud Publica (CIBERESP), Spain 
 
23 Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain 
 
24 Navarre Public Health Institute, Pamplona, Spain 
 
25 Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department, 
San Sebastian, Spain 
 
26 Department of Plastic Surgery, Skane University Hospital, Malmö, Lund University, 
Malmö, Sweden 
 
27 Department of Clinical Sciences in Malmö, Malmö, Sweden 
 
28 Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden 
 
29 Department of Surgical and Perioperative Sciences, Umea University, Umea, Sweden 
 
30 National Institute for Public Health and the Environment (RIVM), Bilthoven, The 
Netherlands, 
 
31 Department of Gastroenterology and Hepatology, University Medical Center, Utrecht, The 
Netherlands. 
 2 
 Abbas 3 
 
32 Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands 
 
33 Clinical Gerontology Unit, University of Cambridge, Cambridge, UK 
 
34 Medical Research Council Epidemiology Unit, Institute of Metabolic Science, University 
of Cambridge, Cambridge, UK 
 
35 Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of 
Oxford, Oxford, UK 
 
36 Nutritional Epidemiology Group, Nutrition and Metabolism Section, International Agency 
for Research on Cancer (IARC), Lyon, France 
 
37  Department of Epidemiology and Biostatistics, School of Public Health, Imperial College 
London, London, UK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
 Abbas 4 
Abstract 
Studies assessing the effects of vitamin D or calcium intake on breast cancer risk have been 
inconclusive. Furthermore, few studies have evaluated them jointly. This study is the largest 
so far examining the association of dietary vitamin D and calcium intake with breast cancer 
risk in the European Prospective Investigation into Cancer and Nutrition.  
During a mean follow-up of 8.8 years, 7,760 incident invasive breast cancer cases were 
identified among 319,985 women. Multivariable Cox proportional hazards regression was 
used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for pre- and 
postmenopausal breast cancer risk. 
Comparing the highest with the lowest quintile of vitamin D intake, HR and 95% CIs were 
1.07 (0.87-1.32) and 1.02 (0.90-1.16) for pre- and postmenopausal women, respectively. The 
corresponding HR and 95% CIs for calcium intake were 0.98 (0.80-1.19) and 0.90 (0.79-
1.02), respectively. For calcium intake in postmenopausal women, the test for trend was 
borderline statistically significant (ptrend=0.05). There was no significant interaction between 
vitamin D and calcium intake and cancer risk (pinteraction=0.57 and 0.22 in pre- and 
postmenopausal women, respectively). 
In this large prospective cohort, we found no evidence for an association between dietary 
vitamin D or calcium intake and breast cancer risk.  
 
Keywords 
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Introduction 
Both epidemiological and experimental data suggest an inverse association between vitamin 
D and breast cancer (1-3). Besides its classical function on calcium homeostasis and bone 
metabolism, vitamin D has potential anticarcinogenic properties with regard to regulation of 
apoptosis, cell differentiation, cell growth and growth factor signaling (4-6). 
Studies assessing the association of vitamin D intake and breast cancer risk have yielded 
inconsistent results. A meta-analysis from 2010 that pooled 11 studies assessing vitamin D 
intake from either diet and/or supplements and breast cancer risk resulted in a significant 
overall association with a RR of 0.91 (0.85 – 0.97) (7). However, there was no significant 
association when assessing vitamin D intake from diet only. Another meta-analysis from 2008 
reported no statistically significant association between dietary vitamin D intake from food or 
supplements and breast cancer risk (8). A number of studies have assessed the relationship 
between breast cancer risk and serum vitamin D metabolites [25(OH)D or 1,25(OH)2D)], the 
biomarkers for vitamin D status in humans, which cover vitamin D from diet, supplements 
and from endogenous production after exposure to sunlight. Most case-control studies 
reported an inverse association between vitamin D status and breast cancer risk (9). However, 
there was no statistically significant inverse association in cohort studies (9), except for a 
recent study in the French E3N Cohort (10). In addition, the Second Expert Report by the 
World Cancer Research Fund (WCRF) classified the evidence as limited (no conclusion) for 
both pre- and postmenopausal breast cancer (11).  
There is less scientific evidence with regard to the anticarcinogenic potential of calcium, 
though effects of calcium on cell proliferation and apoptosis have been reported (12, 13). 
However, due to the tight homeostasis of plasma calcium, it is unclear whether dietary 
calcium may affect breast cancer risk. Various studies assessed the association between 
dietary calcium intake and breast cancer risk with the majority reporting inverse associations 
(3). A meta-analysis pooling data from 6 cohort and 9 case-control studies resulted in a 
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statistically significant inverse association between calcium intake and breast cancer risk. 
However, the results suggest an inverse association in pre- but not in postmenopausal women 
(7). 
Vitamin D intake varies considerably across countries, which may also lead to different risk 
estimates (8). Furthermore, the amount of dietary calcium intake may affect the association 
between dietary vitamin D intake and breast cancer risk. We report here on the association 
between dietary vitamin D and calcium intake from foods and breast cancer risk in a 
heterogeneous population from different countries in Europe within the European Prospective 
Investigation into Cancer and Nutrition (EPIC). Due to its large sample size, EPIC provides 
the opportunity to investigate the association for both pre- and postmenopausal breast cancer 
risk. In addition to main effects, potential interaction effects between dietary vitamin D and 
calcium intake are addressed.  
 
Material and methods 
Study population 
EPIC is a large prospective cohort study conducted since 1992 in 23 centers in 10 European 
countries [Denmark (Aarhus, Copenhagen), France, Germany (Heidelberg, Potsdam), Great 
Britain (Cambridge, Oxford), Greece, Italy (Florence, Varese, Ragusa, Turin, Naples), 
Norway, Spain (Asturias, Granada, Murcia, Navarra, San Sebastian), Sweden (Malmo, 
Umea), The Netherlands (Bilthoven, Utrecht)] with over 500,000 participants (14). Generally, 
the centers recruited the participants from the general population. However, French 
participants were members of a health insurance for school and university employees. Spain 
and Italy recruited participants among blood donors, members of several health insurance 
programs, employees of several enterprises, civil servants but also the general population. 
Participants were recruited from members of screening programs in Utrecht and Florence. In 
France, Norway, Utrecht, and Naples only women were included. Participants from Greece 
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were excluded due to missing validated information on vitamin D and calcium intake. Of the 
342,686 female participants, we excluded 6,822 subjects with missing follow-up information, 
15,019 subjects without dietary information, 837 subjects with in situ breast cancer, and 23 
with not clearly malignant breast tumors (e.g. phyllodes tumors). Thus, the final cohort 
consisted of 319,985 participants. 
 
Exposure assessment   
Diet over the previous twelve months was assessed using dietary assessment instruments that 
were specifically developed for each participating country (14). The questions were structured 
by common food groups except for the questionnaires used in Italy and Spain, where 
questions were structured by country-specific meals. 
All participants were asked to report their average consumption of each food item over the 
previous twelve months by structured categories ranging from never or less than once per 
month to six or more times per day. All dietary measurement instruments have been validated 
previously in a series of studies within the various source populations participating in EPIC 
(15). 
To collect information on education, medical history (surgeries and previous illnesses), 
tobacco and alcohol consumption, and physical activity and other lifestyle factors, a further 
questionnaire was used. Height and weight were measured at baseline, except for most 
participants recruited at the Oxford study center, and in France as well as all participants 
recruited in Norway. Self-reported data were available for the latter centres (14). 
Menopausal status at baseline was defined as described previously using an algorithm that 
accounts for information on menstrual status/history, type of menopause, use of oral 
contraceptives and menopausal hormones (16).  
 
Outcome assessment 
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In most countries (Denmark, Italy, The Netherlands, Norway, Spain, Sweden, and the 
UK) incident cancers were identified through linkage with population registries. Cancer cases 
were further identified by active follow-up, through a health insurance company (France) or 
direct contacts with study subjects, their doctors or their next of kin (France, Germany, and 
Greece). Mortality data were also obtained from either the cancer or mortality registries at the 
regional or national level. Participants from centers that relied on registry data that have been 
reported to IARC were censored between December 2002 and December 2005, depending on 
the study center. For Germany and Greece, the end of the follow up was considered to be the 
last known contact, the date of diagnosis, or the date of death, whichever came first. Cancer 
incidence was coded according to ICD-O-2.  
 
 
Statistical analysis 
Participants were categorized according to quintiles of dietary intake of vitamin D and 
calcium. Cox proportional hazards regression was used to examine the association of dietary 
intake of vitamin D or calcium and breast cancer risk. Age was used as the primary time 
variable in the Cox models. Time at entry was age at recruitment, exit time was age when 
participants were diagnosed with cancer, died, were lost to follow-up, or were censored at the 
end of the follow-up period, whichever came first. Analyses were stratified by center to 
account for center effects such as follow-up procedures and questionnaire design, and by 1-
year categories of age at recruitment to account for possible violations of the proportional 
hazard assumption. 
Different models were run to fully disentangle the effects of dietary vitamin D and calcium on 
breast cancer risk: model 1, energy-adjusted only (kcal/day, quintiles); model 2, further 
adjustment for potential confounders and risk factors defined a-priori: total energy excluding 
energy from fat and alcohol (kcal/day, quintiles), fat (g/day, quintiles, monounsaturated, 
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polyunsaturated and saturated fat), alcohol consumption (g/day, quintiles), weight (kg, cont.), 
height (cm, cont.), smoking status (never, former, current, unknown), education level (none or 
primary school, technical/professional school, secondary school, longer education incl. 
university degree, unknown), menopausal status (premenopausal, perimenopausal, 
postmenopausal), total physical activity (inactive, moderately inactive, moderately active, 
active, missing), current use of oral contraceptives or hormones for menopause (yes, no, 
unknown), age at menarche (d12, 13-14, e15 years, missing); model 3, further adjustment on 
vitamin D (µg/day, quintiles) and calcium intake (mg/day, quintiles) in the calcium and 
vitamin D models, respectively. We adjusted for non-fat, non-alcohol energy and 
independently adjusted for alcohol and fat to account for both nutrients as potential 
confounders. In a sensitivity analysis we recalculated the models for all, pre- and 
postmenopausal women using the complete case analysis. 
Multiplicative statistical interaction was evaluated with the likelihood-ratio-test by including 
cross-product terms of the potential interaction variables (continuous intake variables for 
vitamin D and calcium) in the respective models. Tests for trend were performed using the 
Wald statistic of the continuous intake variable.  
In order to compare results across populations with different levels of sunlight exposure, the 
EPIC centres were divided into 7 latitude groups: below 42°N (Granada, Murcia, Ragusa, and 
Naples); 42°N - 44°N (Asturias, Navarra, San Sebastian, Florence, and South coast of France 
– centred in Marseille); 45°N - 46°N (Varese, Turin, and South of France – centred in Lyon); 
47°N - 49°N  (North-East and West of France – centred in Nantes and Paris, respectively – 
and Heidelberg); 50°N  - 51°N  (Potsdam, Utrecht, Bilthoven, Cambridge, and Oxford); 52°N  
- 56°N  (Malmö, Aarhus, and Copenhagen); and above 57°N  (Norway, and Umeå)  
To correct for measurement error, FFQ dietary intake data were calibrated against 24-hour 
dietary recall data obtained from a random sample of the subcohort (N = 36,994). A fixed-
effects linear model was used in which center and sex-specific 24-h recall data were regressed 
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on the FFQ intakes (17-19). The calibrated FFQ data were used to model dietary intake of 
vitamin D or calcium continuously. All tests were two-sided and considered to be statistically 
significant with a p-value of < 0.05. All analyses were performed in SAS software version 9.2 
(Cary, NC, US). 
 
 
Results 
Mean follow-up time for the study population was 8.8 years. Mean time from baseline until 
breast cancer diagnosis was 5.1 years. During the follow-up, a total of 7,760 incident invasive 
(primary, malignant) breast cancer cases were identified, including 1,802 women who were 
premenopausal at recruitment and 4,259 cases in women who were postmenopausal at 
recruitment. Descriptive characteristics (at baseline) of the total cohort of 319,985 women are 
shown in Table 1. Women in the highest quintile of both vitamin D and calcium intake had a 
higher non-fat energy intake and a higher fat intake as compared to women in the lowest 
quintile. Furthermore, women in the lower quintile of vitamin D intake weighed less, used 
oral contraceptives less frequently, were younger at menarche, and were more often non-
smokers.  
As shown in Table 2, dietary vitamin D intake was highest in EPIC Sweden as compared to 
the other countries; calcium intake was highest in Denmark and the Netherlands. 
Dietary vitamin D intake was not associated with overall breast cancer risk (ptrend = 0.92; 
Table 3), There was also no association when addressing pre- or postmenopausal women 
separately.  
We found some indication for an inverse association between dietary calcium intake and 
breast cancer risk. The hazard ratio (HR) (95% confidence interval (CI)) for the highest as 
compared to the lowest quintile was 0.91 (0.83–1.01) (Table 3). The test for trend did not 
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reach statistical significance (ptrend = 0.06). Stratification by menopausal status indicated a 
possible association in postmenopausal women 0.90 (0.79–1.02), (ptrend = 0.05).  
In the complete case analysis results were similar to those when using confounders with a 
category for missing data for both dietary vitamin D and calcium intake. 
 
As dietary vitamin D may modify the association between calcium intake and breast cancer 
risk (and vice versa), we assessed potential interaction effects between both nutrients. 
However, statistical significant interaction (p-interaction = 0.44; 0.57 and 0.22 for all, 
premenopausal and postmenopausal women, respectively; data not shown) was not observed.  
Moreover, additional adjustment by vitamin D (µg/day, quintiles) and calcium intakes 
(mg/day, quintiles) in the calcium and vitamin D models, respectively, did not result in 
changes of the risk estimates (data not shown). 
To correct for potential measurement error, we repeated the analysis with the questionnaire 
data calibrated against 24-h recall data for the continuous intake variables. The overall 
associations were 1.00 (95% CI: 0.99-1.01; p = 0.92; uncalibrated) and 1.02 (95% CI: 0.99-
1.06; p = 0.22; calibrated) per 1 µg/day increment of dietary vitamin D and 0.99 (95% CI: 
0.99-1.00; p. = 0.06; uncalibrated) and 0.99 (95% CI: 0.97-1.00; p = 0.11; calibrated) per 100 
mg/day increment of calcium intake.  
In a country-specific analysis with the continuous calibrated intake values there was no 
statistically significant association between either vitamin D or calcium intake and overall 
breast cancer risk. Country-specific results by menopausal status also showed no significant 
associations except for an increased breast cancer risk associated with calcium intake in 
premenopausal women in the Netherlands (p = 0.01) (data not shown). 
As a proxy for sun exposure and thus endogenous vitamin D production we divided the 
centres in 7 categories according to their latitude. Adjustment for latitude did not change the 
observed risk estimates for vitamin D and breast cancer risk. Moreover, we calculated 
 11 
 Abbas 12 
separate risk estimates for each latitude. There was no significant association between vitamin 
D and breast cancer risk in any of the latitude groups (pheterogeneity = 0.37).  
 
Discussion 
 
The present study is so far the largest prospective study including data from nine European 
countries that assessed dietary vitamin D or calcium intake and breast cancer risk. Dietary 
vitamin D and calcium intake was not associated with breast cancer risk. There was also no 
significant interaction between both nutrients.  Evidence for an association between dietary 
vitamin D intake and breast cancer risk has not been consistent in cohort studies, which 
reported a significant inverse association only in premenopausal women (20), in 
postmenopausal women with ER positive tumors (21) or no significant association at all (22-
28). Four out of eight case-control studies, three of which included premenopausal women 
only, did not find an association (29-33), three reported significantly inverse associations (34-
36), whereas one study reported a non-significantly increased risk with higher dietary vitamin 
D intake (37). A meta-analysis that pooled results from 11 studies assessing total vitamin D 
intake and breast cancer risk resulted in a significant overall inverse association with risk of 
0.91 (0.85 – 0.97) (7). However, when differentiated by source of vitamin D, the significant 
inverse association was seen in vitamin D supplement users only but no association existed 
when analysing dietary vitamin D intake from foods. Also, a meta-analysis from 2008 
reported no significant association between dietary vitamin D intake from food or 
supplements and breast cancer risk (8). However, the authors observed a significant inverse 
association when restricting the analysis to women taking more than 10µg/day vitamin D. 
Thus, the amount of dietary intake in the present population may be too low to detect a 
potential effect. Intake of dietary vitamin D in the present study was somehow comparable 
with dietary intake, but not total intake values reported in US studies (20, 21). In contrast, 
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dietary calcium intake in EPIC is somehow higher than reported dietary intake in the US (20, 
21). Unfortunately, we did not have information on supplemental vitamin D intake nor on sun 
exposure as primary source of vitamin D. We, however, adjusted in the regression analysis for 
physical activity which may in part account for sun exposure, with a marginal effect on risk 
estimates. In a sensitivity analysis, we also adjusted for centers’ latitude as another proxy for 
sun exposure, which also did not affect the risk estimates. Furthermore analyses were 
stratified by centres latitude which may in part account for differential effects of sun exposure 
by region. In contrast to Engel et al. (26), who observed a decreased postmenopausal breast 
cancer risk associated with vitamin D intake in regions with high ultraviolet radiation dose, 
we did not find any evidence for a differential effect of dietary vitamin D on pre- or 
postmenopausal breast cancer risk in regions with different sun exposure. 
Studies accounting for total vitamin D status by measuring 25(OH)D in plasma or serum have 
yielded mostly significant inverse associations in case-control studies but, except for one 
study (10), no associations with risk in cohort studies (9).  
We did not observe a statistically significant association between dietary calcium and breast 
cancer risk in pre- or postmenopausal women. However, we found some indication of an 
inverse association in postmenopausal women with borderline significance (ptrend = 0.05).  
Most case-control studies reported an inverse association (37-46), although statistically 
significant only in a subset (40, 41, 45, 46) and no association was observed in three studies in 
premenopausal women only (30, 31, 34). Cohort studies reported a reduced risk of breast 
cancer associated with dietary calcium (20, 21, 24, 47, 48), including two studies in 
premenopausal women only (20, 24) and one in estrogen receptor-/progesterone receptor-
negative tumors only (48), or no significant association (33, 49). The results of the largest trial 
so far, the Women’s Health Initiative, did not demonstrate an inverse association between 
breast cancer risk and calcium plus vitamin D supplementation (50). However, a recent 
reanalysis of the WHI data provided evidence for a protective effect of vitamin D and calcium 
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supplementation in women who were not taking further personal supplements, indicating that 
supplementation may only be effective in those women who were deficient (51). 
Calcium might exert its potential anticarcinogenic properties via several mechanisms 
including effects on cell proliferation, apoptosis or cell differentiation (3, 12, 13). So far, 
differential anticarcinogenic mechanisms on pre- and postmenopausal breast cancer are not 
known. However, a meta-analysis pooling data from 15 studies reported a statistically 
significant inverse association in pre-/perimenopausal women but not postmenopausal women 
(7). 
Further studies have concentrated on measurement of calcium in serum samples as a marker 
of a subject’s calcium status (52-54). Results have been inconsistent, showing significant 
positive (53) or negative associations (52) in premenopausal women or no significant 
association at all (54). However, as the calcium metabolism and thus serum calcium levels are 
tightly regulated, blood levels of calcium may not be a good marker for calcium status or 
dietary calcium intake (55).  
In line with previous studies, our results do not suggest an interaction between vitamin D and 
calcium intake (20, 33, 34), nor that the associations were confounded by each other. In 
contrast, another study reported a borderline significant interaction between both nutrients in 
postmenopausal women (p = 0.05) with a non-significant inverse association for calcium 
intake in the group with the highest tertile vitamin D intake (24). 
 
Strengths of the study are its prospective design, the calibration of food frequency 
questionnaire data against 24-h-recall data to reduce measurement error, as well as the 
inclusion of participants from different European countries reflecting a wide range of intake. 
However, several limitations have to be taken into account. We did not have information on 
the overall vitamin D status, including vitamin D from endogenous synthesis and vitamin D 
from supplements. Vitamin D supplementation varies across European countries. Especially 
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in the Northern countries, vitamin D from supplements, e.g. cod liver oil, is frequently used 
and thus one of the most important sources of vitamin D (56). Since the contribution of diet to 
the overall vitamin D status of a person is limited (not more than 10-20% of vitamin D may 
originate from dietary sources), studies with information on the entire vitamin D status may 
come to another conclusion. Moreover, we assessed nutrient intake at only one point in life 
time. It is currently unknown at what point in time vitamin D or calcium intake may affect 
breast cancer risk. However, a recent study measuring ultraviolet sunlight exposure as a proxy 
for vitamin D production suggest that exposure in both adolescence and adulthood may 
reduce breast cancer risk (57) 
 
In summary, the present study does not support an association of dietary vitamin D or calcium 
intake with breast cancer risk. Further research assessing vitamin D and breast cancer risk 
should focus on biomarker measurement to account for the overall vitamin D status as dietary 
intake may be too low to detect potential anticarcinogenic effects 
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Table 1: Descriptive characteristics of the EPIC cohort according to the lowest and highest vitamin D and calcium intake 
 Total cohort Dietary vitamin D intake3 Dietary calcium intake3 
   Lowest quintile Highest quintile Lowest quintile Highest quintile 
Age (years), mean  (SD) 50.2 (9.7) 48.9 (10.7) 50.3 (9.4) 49.1 (8.9) 50.9 (9.9) 
Height (cm), mean (SD) 162.6 (6.6)  161.0 (6.6) 164.7 (6.3) 162.5 (6.7) 163.1 (6.5) 
Weight (kg), mean (SD) 65.5 (11.6) 63.1 (11.2) 67.7 (11.8) 65.8 (11.7) 65.9 (11.8) 
Ethanol intake (g/d), mean (SD) 8.3 (11.8) 7.7 (11.8) 6.7 (10.1) 6.9 (11.1) 9.1 (12.3) 
Non-fat energy intake (kcal/d), mean (SD) 1196 (342) 1079 (317) 1263 (330) 919 (233) 1496 (340) 
FAMS (g/d), mean (SD) 27.4 (11.1) 23.8 (10.1) 28.7 (10.5) 20.8 (8.1) 34.3 (12.6) 
FAPU (g/d), mean (SD) 13.5 (5.9) 11.8 (5.9) 15.6 (5.9) 10.9 (4.8) 16.0 (6.6) 
FASAT (g/d), mean (SD) 29.7 (11.8) 23.9 (9.7) 33.0 (12.4) 20.9 (7.5) 39.8 (13.1) 
Education1      
  Primary school completed (%) 24.0 25.3 25.4 29.0 20.6 
  University degree (%) 23.0 27.4 17.6 18.7 25.1 
  Missing (%) 4.5 5.5 3.0 3.3 4.7 
Smoking status      
  Never (%) 54.8 62.3 44.9 49.2 56.2 
  Former (%) 23.4 20.4 26.5 23.2 24.2 
  Current (%) 19.6 15.4 26.0 25.1 17.5 
  Missing (%) 2.2 1.9 2.5 2.5 2.1 
Age at menarche      
  d12 years (%) 35.2 39.4 29.4 33.5 35.7 
  13-14 years (%) 46.1 46.2 47.6 46.6 45.8 
  e15 years (%) 15.2 13.3 18.0 15.7 15.7 
  Missing (%) 3.5 1.2 5.0 4.2 2.9 
Current use of oral 
contraceptives/hormones for menopause      
  Yes 22.1 20.0 23.7 22.9 21.8 
  No 71.4 76.1 68.2 69.8 72.7 
  Missing (%) 6.5 3.9 8.1 7.4 5.6 
Physical activity2      
  Inactive (%) 12.2 14.5 7.2 10.7 12.0 
  Moderately inactive (%) 29.6 36.4 17.4 22.0 33.3 
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  Moderately active (%) 34.6 39.4 26.9 28.4 38.7 
  Active (%) 7.6 7.1 7.2 5.1 10.9 
  Missing (%) 16.0 2.6 41.22 33.82 5.1 
1 not all degrees listed, 2 physical activity data from Norway and 47% from Sweden are missing, in Norway calcium intake was low, and in Sweden and Norway vitamin D intake high, thus missing 
categories differ strongly between the quintiles; 3 Dietary intake from FFQ data, FAMS = monounsaturated fatty acids, FAPU = polyunsaturated fatty acids, FASAT = saturated fatty acids 
 
 
 
 
Table 2: Dietary vitamin D and calcium intake in the respective countries of the EPIC cohort 
 
 N, 
total  
cohort 
Follow-Up time  
in person years 
N, 
breast cancer 
cases 
Vitamin D intake  
(µg/day) 
Mean 1  
Calcium intake  
(mg/day) 
Mean 1 
Denmark  28,694 215,799 822 4.67 1010 
France  67,696 739,238 2844 2.68  907 
Germany  27,864 227,045 455 3.63 959 
Italy  30,434 256,918 673 2.08 818 
Norway 35,226 210,297 470 4.15 808 
Spain  24,809 241,082 316 5.00 981 
Sweden  26,287 270,596 679 7.15 938 
The Netherlands 26,432 228,577 564 4.31 1046 
United Kingdom  52,543 441,127 937 3.74 968 
1 dietary intake from foods; data derived from 24-h diet recalls obtained in a subcohort (N = 36,994) 
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Table 3: Dietary vitamin D and calcium intake and risk of pre- and postmenopausal breast cancer 
 
Vitamin D (µg/day) 
   All women   
Premenopausal 
women  
Postmenopausal  
women 
      Model 11   Model 22   Model 22   Model 22 
       HR 95 % CI   HR 95 % CI   HR 95 % CI   HR 95 % CI 
 Quintiles (range) 
Median 
intake  
Cases 
(N)                
 Q1 (<1.85) 1.35 1563 1.00    1.00    1.00    1.00   
 Q2 (1.85 - <2.69) 2.27 1640 0.95 0.88 1.02  0.94 0.87 1.01  0.98 0.85 1.13  0.90 0.82 0.99 
 Q3 (2.69 - <3.68) 3.15 1673 1.02 0.95 1.10  1.01 0.94 1.09  1.14 0.99 1.32  0.97 0.87 1.07 
 Q4 (3.68 - <5.46) 4.39 1531 1.00 0.93 1.09  0.99 0.91 1.08  1.04 0.88 1.23  0.99 0.89 1.11 
 Q5 (e 5.46) 7.35 1353 1.03 0.94 1.13  1.04 0.94 1.14  1.07 0.87 1.32  1.02 0.90 1.16 
 p for trend3   0.92    0.92    0.78    0.21   
Calcium (mg/day)                                  
 Quintiles (range)                  
 Q1 (<635) 516 1281 1.00    1.00    1.00    1.00   
 Q2 (635 - <815) 730 1543 1.02 0.94 1.10  1.00 0.92 1.08  0.97 0.82 1.13  1.01 0.91 1.12 
 Q3 (815 - <992) 900 1575 0.96 0.88 1.04  0.93 0.86 1.01  0.92 0.77 1.09  0.94 0.84 1.05 
 Q4 (992 - <1,231) 1,097 1640 0.94 0.87 1.03  0.92 0.84 1.00  0.85 0.70 1.02  0.95 0.85 1.07 
 Q5 (e 1,231) 1,440 1721 0.93 0.85 1.02  0.91 0.83 1.01  0.98 0.80 1.19  0.90 0.79 1.02 
 p for trend3    0.05       0.06       0.85       0.05     
1 Cox proportional hazard model stratified by age and center adjusted for energy intake (kcal/day, quintiles)  
2 Cox proportional hazard model stratified by age and center, adjusted for no-fat, no-alcohol energy (kcal/day, quintiles), fat (g/day, quintiles, monounsaturated, polyunsaturated, and saturated fat), 
alcohol consumption (g/day, quintiles), weight (kg, cont.), height (cm, cont.), smoking status (never, former, current, unknown), education level (none or primary school, technical/professional school, 
secondary school, longer education incl. university degree, unknown), menopausal status (premenopausal, postmenopausal, perimenopausal), current use of contraceptives or hormones (yes, no, 
unknown), physical activity (occupational, recreational and household activity; inactive, moderately inactive, moderately active, active, missing), age at menarche (d12, 13-14, e15, missing) 
3 Wald statistic of the continuous variable. 
HR=hazard ratio, CI=confidence interval, 1 µg vitamin D = 40 IU vitamin D 
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